Renk Stock Defies Placement Pressure as Record Backlog and Short Bets Collide

The tug-of-war between operational strength and market skepticism at Renk Group has taken a new twist. While the company’s order book swells to historic levels, a secondary share sale by its largest shareholder was absorbed without the usual carnage — even as short sellers step up their wagers against the stock.

Deal Digest: A Rarely Seen Aftermath

KNDS, the Franco-German defense group, offloaded 5.8 million Renk shares at €45.10 apiece, a discount of roughly 2.5% to the prior day’s close. The block trade, worth around €262 million in gross proceeds, reduced KNDS’s stake from 15.83% to approximately 10%. Unlike most accelerated placements — where the shares often take weeks to recover — Renk’s stock actually gained ground on the day, trading near €48.24, up roughly 6%. The muted selling pressure was all the more remarkable compared with the 8.5% discount Springer Nature suffered in a contemporaneous placement by BC Partners, which triggered a 7% drop there.

KNDS is selling to raise liquidity ahead of its own planned dual listing in Paris and Frankfurt this summer. The remaining 10% stake comes with a 180-day lock-up, effectively removing the threat of further overhang from that quarter in the short term.

Record Orders Meet Rising Skepticism

The operational backdrop helps explain why the market took the dilution in stride. Renk posted a first-quarter order intake of €582 million, up 6.1% year-on-year and the best start to a fiscal year in the company’s history. The order backlog now stands at a hefty €6.9 billion. Adjusted operating profit came in at roughly €42 million, lifting the margin to 15%.

Should investors sell immediately? Or is it worth buying Renk?

But not everyone is buying the story. Two major hedge funds have built short positions: Citadel Advisors holds a net short of 0.5%, while PDT Partners has increased its short from 0.79% to 0.84%. BlackRock, meanwhile, has raised its voting rights stake to 4.44%, betting on the long-term structural growth in defense spending.

Headwinds Beneath the Surface

The short sellers have tangible reasons for caution. Renk supplies components for Israeli armored vehicles, and potential export restrictions put as much as €100 million in revenue at risk for the current year. Another €200 million in revenue from the prior year has shifted into the first half of 2025, creating a lumpy earnings pattern that complicates near-term visibility.

Despite these hurdles, management reaffirmed its full-year guidance: revenue of more than €1.5 billion, with a longer-term target of roughly €3 billion by the end of the decade. For fiscal 2025, the company already delivered revenue up nearly 20% to €1.37 billion and adjusted EBIT climbing 21.7% to €230 million.

Analysts Stay Constructive on the Dip

The current share price of around €48 remains light-years from the 52-week high of €88.73 touched last October, leaving the stock down roughly 12.6% for the year. Yet the KNDS sale has at least interrupted the decline, with the stock now about 10% above the 52-week low of €43.91 set in mid-May.

Renk at a turning point? This analysis reveals what investors need to know now.

Analyst ratings reflect cautious optimism: mwb research rates the stock a “Buy” with a €53 target, Warburg Research also says “Buy” at €63, and Goldman Sachs calls it “Neutral” at €65. The improved free float from the placement is seen as a positive for liquidity in the MDAX-listed shares.

What’s Next for Investors

The next major catalyst comes on June 10, when Renk’s management meets shareholders at the annual general meeting. A dividend of €0.58 per share is on the table for approval. Meanwhile, the operational partnership with KNDS on Leopard 2 tank drive systems remains unchanged, ensuring the two companies continue to work closely regardless of the reduced equity link.

Ad

Renk Stock: New Analysis - 20 May

Fresh Renk information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Renk analysis...

en | DE000RENK730 | RENK | boerse | 69381978 |